Summit to Spotlight Growing Sector
About 250 industry and education leaders are set to take part in today's Indiana Life Sciences Summit. The 11th annual event will feature sessions on accelerating research, attracting capital and commercialization. BioCrossroads Chief Executive Officer David Johnson says the summit will also include an update on the Indiana Biosciences Research Institute, including efforts to recruit talent, a location and fundraising. Inside INdiana Business Host Gerry Dick will moderate two panels at today's event.
Indiana Life Sciences Summit Agenda
Wednesday, October 15 agenda includes:
Keynote Address: Christopher P. Austin, M.D., Director of National Center for Advancing Translational Sciences
Panel I: Exploring New Avenues to Accelerate Research
Moderator: Debra Lappin, Principal, Faegre Baker Daniels Consulting and President, Council for American Medical Innovation
Michael D. Clayman, M.D., CEO, Flexion Therapeutics
Annalisa Jenkins, MBBS, MRCP, CEO, Dimension Therapeutics
Jack Phillips, President and CEO, Roche Diagnostics
Pete Yonkman, President, Cook Medical
Panel II: Indiana Biosciences Research Institute's Approach to Quicker Commercialization
Moderator: Gerry Dick, President and Managing Editor, Grow INdiana Ventures / Host and Creator of Inside Indiana Business with Gerry Dick
David Broecker, COO, Indiana Biosciences Research Institute
Andrew M. Dahlem, D.V.M. (h.c.) Ph.D., Vice President, LRL Operations / LRL Europe, Eli Lilly and Company
Jay Hess, M.D., Ph.D., M.H.S.A., Dean, Indiana University School of Medicine; Vice President for University Clinical Affairs, Indiana University
Luke Kenley, Senator, Indiana State Senate
Panel III: The Need for Capital and its Impact on Innovation and Research
Moderator: Gerry Dick, President and Managing Editor, Grow INdiana Ventures / Host and Creator of Inside Indiana Business with Gerry Dick
Representative from Battelle Technology Partnership
Nadim Barakat, Managing Director, Carlyle Group
Mark Skinner, Vice President of the State Sciences & Technology Institute
Derek Small, Co-Founder and Executive Chairman, Assembly Pharmaceuticals
Don't miss this unique opportunity to network and learn more about the future of Indiana's life sciences industry which accounts for a $55 billion impact on our economy, employs more than 58,000 Hoosiers, and exports nearly $10 billion worth of new products each year.
Source: BioCrossroads